Top Markets
Coin of the day
Voyageur Pharmaceuticals Ltd. Voyageur Pharmaceuticals Ltd.

Voyageur Pharmaceuticals Ltd.

VM
Rank in Stocks #29609
Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based... Voyageur Pharmaceuticals Ltd. specializes in the creation of mineral-based active pharmaceutical ingredients (APIs). The company aims to produce radiocontrast agents utilizing barium and iodine, along with pharmaceutical products derived from bromine. It possesses complete ownership of three barium sulfate deposits in British Columbia, Canada, two of which are of a quality appropriate for the pharmaceutical barite sector. Furthermore, Voyageur holds stakes in a valuable brine project in Utah, United States, known for its high concentrations of iodine, lithium, and bromine. The company transitioned from its previous name, Voyageur Minerals Ltd., to Voyageur Pharmaceuticals Ltd. in December 2019. Its corporate headquarters are located in Calgary, Canada.
Share Price
$0.12109959
Market Cap
$21.73M
Change (1 day)
3.13%
Change (1 year)
8.32%
Country
CA
Trade Voyageur Pharmaceuticals Ltd. (VM)

Category

P/B ratio for Voyageur Pharmaceuticals Ltd. (VM)
P/B ratio as of 2026 TTM: 0
According to Voyageur Pharmaceuticals Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Voyageur Pharmaceuticals Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors